Handelsbanken Fonder
RNAM

Handelsbanken Fonder’s Avidity Biosciences RNAM Stock Holding History

Handelsbanken Fonder’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,700
Closed -$2.94M – 1519
2025
Q4 		$2.94M Buy
40,700
+6,200
+18% +$400K 0.01% 619
2025
Q3 		$1.5M Buy
34,500
+6,400
+23% +$259K ﹤0.01% 839
2025
Q2 		$798K Buy
28,100
+1,000
+4% +$29.8K ﹤0.01% 1050
2025
Q1 		$800K Hold
27,100
– – ﹤0.01% 1029
2024
Q4 		$788K Buy
+27,100
New +$1.13M ﹤0.01% 1085

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Handelsbanken Fonder's RNAM Position: Q1 2026 in Review

Handelsbanken Fonder sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 40,700 shares — an estimated $2.94M sold.

Handelsbanken Fonder first reported a position in RNAM in Q4 2024 and held it in 5 quarters. The position peaked at $2.94M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Handelsbanken Fonder reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Handelsbanken Fonder sold 40,700 Avidity Biosciences shares in Q1 2026, an estimated $2.94M.
  • Handelsbanken Fonder first reported a position in Avidity Biosciences in Q4 2024 and held it in 5 quarters.
  • Handelsbanken Fonder's Avidity Biosciences position peaked at $2.94M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Handelsbanken Fonder's 13F filing for Q1 2026, filed 28 Apr 2026.